Redeye: Strax - Advancing Into New Markets

Report this content

Redeye remains positive to STRAX after a Q1-report overall in-line with our expectations. We expect a tough Q2 with significant uncertainty, which could create a long-term buying opportunity. We encourage investors to raise their view as the second half of the year, which remains the most important period for STRAX.


Read more and download the research update:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.